Authorised representative (AR)

Angeion Medical HK Limited

安健医疗香港有限公司
Hong Kong MDACS·9 represented devices·4 applicants·May 04, 2018Sep 09, 2024
9
Total devices
4
Applicants
2018
First representation
2024
Most recent
AR overview
Bilingual authorised representative information and contact details
Authorised representative (EN)
Angeion Medical HK Limited
Authorised representative (ZH)
安健医疗香港有限公司
Phone
96886105
Timeline
First representation
May 04, 2018
Most recent
Sep 09, 2024
Risk class distribution
IV
9
Applicant partnerships
Top manufacturers represented by this AR
Recent registrations
Latest 15 MDACS listings represented by Angeion Medical HK Limited
DeviceRisk classApplicantRegistered
Catheters, Vascular, Angioplasty, Balloon, Peripheral Artery, Drug Delivery
导管、血管、血管成形术、球囊、外周动脉、药物输送
IVConcept Medical B.V.
Concept Medical B.V.
Sep 09, 2024
Catheters, Vascular, Angioplasty, Balloon, Peripheral Artery, Drug Delivery
导管、血管、血管成形术、球囊、外周动脉、药物输送
IVConcept Medical B.V.
Concept Medical B.V.
Aug 29, 2024
Catheters, Vascular, Angioplasty, Balloon, Coronary
导管、血管、血管成形术、球囊、冠状动脉
IVBrosMed Medical Co., Ltd
广东博迈医疗科技股份有限公司
Jul 24, 2024
Catheters, Vascular, Angioplasty, Balloon, Coronary
导管、血管、血管成形术、球囊、冠状动脉
IVBrosMed Medical Co., Ltd
广东博迈医疗科技股份有限公司
Feb 19, 2024
Stents, Vascular, Coronary, Balloon-Expandable, Drug-Eluting
血管支架、冠状动脉支架、球囊扩张支架、药物洗脱支架
IVEnvision Scientific Pvt. Ltd.
Envision Scientific Pvt. Ltd.
Aug 29, 2023
Catheters, Vascular, Angioplasty, Balloon, Coronary, Drug Delivery
导管、血管、血管成形术、球囊、冠状动脉、药物输送
IVEnvision Scientific Pvt. Ltd.
Envision Scientific Pvt. Ltd.
Feb 08, 2023
Catheters, Vascular, Angioplasty, Balloon, Coronary
导管、血管、血管成形术、球囊、冠状动脉
IVBrosMed Medical Co., Ltd
广东博迈医疗科技股份有限公司
Feb 08, 2023
Catheters, Vascular, Angioplasty, Balloon, Coronary
导管、血管、血管成形术、球囊、冠状动脉
IVGenoss Co., Ltd.
Genoss Co., Ltd.
May 04, 2018
Catheters, Vascular, Angioplasty, Balloon, Coronary
导管、血管、血管成形术、球囊、冠状动脉
IVGenoss Co., Ltd.
Genoss Co., Ltd.
May 04, 2018
About this profile

Angeion Medical HK Limited serves as the authorised representative for 9 medical devices in Hong Kong's MDACS framework. Analyse applicant partnerships, risk class exposure, and recent regulatory activity to understand their market footprint.